About this trial
In this monocentric observational study the research question is to what extent data collected via Apple Watch can predict the heart failure status of decompensated HF patients. For this purpose, physiological data from the Apple Watch (such as single-lead electrocardiogram, SpO2, respiratory rate, step count, nighttime temperature, etc.) will be extracted and used as predictor variables to forecast outcomes like risk of decompensation and rehospitalization within the follow-up period. Since this is a data-driven study, additional data collected as part of guideline-compliant treatment will also be included.
Eligibility criteria
Qualifiers
age over 17
HFrEF with LV-EF under 41
hospitalized for decompensated heart failure with a) nTproBNP over 1000 AND b) willing to participate AND c) at least one out of three clinical signs (edema, pleural effusion, ascites)
Disqualifiers
life expectancy under 6 months due to non-cardiac conditions
inability to use smartwatch
severe valvular lesions
Trial design
Treatments tested in this trial
- Monitoring with Apple Watch
Treatment groups
Locations
1Map coordinates are unavailable for these locations. Locations are shown below instead.